NF-kappaB is involved in the regulation of EMT genes in breast cancer cells BRB Pires, AL Mencalha, GM Ferreira, WF De Souza, JA Morgado-Díaz, ... PloS one 12 (1), e0169622, 2017 | 289 | 2017 |
NF-kappaB: two sides of the same coin BRB Pires, RCMC Silva, GM Ferreira, E Abdelhay Genes 9 (1), 24, 2018 | 242 | 2018 |
Targeting cellular signaling pathways in breast cancer stem cells and its implication for cancer treatment BRB Pires, ÍSS DE AMORIM, LDE Souza, JA Rodrigues, AL Mencalha Anticancer research 36 (11), 5681-5691, 2016 | 68 | 2016 |
Label‐Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer BRB Pires, C Panis, VD Alves, ACSA Herrera, R Binato, L Pizzatti, ... Oxidative Medicine and Cellular Longevity 2019 (1), 5357649, 2019 | 24 | 2019 |
Twist1 correlates with epithelial-mesenchymal transition markers fibronectin and vimentin in adrenocortical tumors D Bulzico, BRB Pires, PAS DE FARIA, LV Neto, E Abdelhay Anticancer research 39 (1), 173-175, 2019 | 14 | 2019 |
NF-kappaB regulates redox status in breast cancer subtypes BRB Pires, R Binato, GM Ferreira, R Cecchini, C Panis, E Abdelhay Genes 9 (7), 320, 2018 | 14 | 2018 |
Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology R Kern, SC Correa, TB Scandolara, J Carla da Silva, BR Pires, C Panis Personalized Medicine 17 (5), 399-420, 2020 | 11 | 2020 |
Comparative proteomical and metalloproteomical analyses of human plasma from patients with laryngeal cancer CPC Gomes, MS Freire, BRB Pires, EAR Vasconcelos, TL Rocha, ... Cancer immunology, immunotherapy 59, 173-181, 2010 | 11 | 2010 |
Is there a role for epithelial-mesenchymal transition in adrenocortical tumors? D Bulzico, PAS Faria, CB Maia, MP de Paula, DC Torres, GM Ferreira, ... Endocrine 58, 276-288, 2017 | 9 | 2017 |
A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma D Bulzico, DC Torres, GM Ferreira, BRB Pires, PAS de Faria, R Hassan, ... Endocrine Pathology 28, 326-331, 2017 | 8 | 2017 |
NF-kappaB: Two sides of the same coin. Genes (Basel) 9 (1): 24 BRB Pires, R Silva, GM Ferreira, E Abdelhay | 7 | 2018 |
The Hypoxia-Inducible Factor-1 [alpha] signaling pathway and its relation to cancer and immunology BRB Pires, AL Mencalha, GM Ferreira, C Panis, RCMC Silva, E Abdelhay American Journal of Immunology 10 (4), 215, 2014 | 7 | 2014 |
An Overview Regarding Pharmacogenomics And Biomarkers Discovery: Focus On Breast Cancer TB Scandolara, BRB Pires, B Vacario, ISS de Amorim, PB Siqueira, ... Current topics in medicinal chemistry, 2022 | 5 | 2022 |
Twist1 influences the expression of leading members of the IL-17 signaling pathway in HER2-positive breast cancer cells BRB Pires, R Binato, GM Ferreira, S Corrêa, B Du Rocher, D Bulzico, ... International Journal of Molecular Sciences 22 (22), 12144, 2021 | 4 | 2021 |
Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in … AS Gehren, WF de Souza, ACM Sousa‐Squiavinato, DAA Ramos, ... Cell Biology International 47 (9), 1638-1649, 2023 | 3 | 2023 |
Low Plasmatic 25-hydroxyvitamin D at Diagnosis is Associated with Axillary Invasion, Chemoresistance and Metastasis in Women with Breast Cancer PL Micheletti, D Rech, VJ Victorino, ACS do Amaral, R Kern, BR Pires, ... Archives of Medical Research 51 (6), 542-547, 2020 | 2 | 2020 |
Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions I Maocha, B Rosado, J Lopes-Nunes, M Lopes, J Rolo, B Pires, ... Pharmaceutics 16 (7), 864, 2024 | 1 | 2024 |
Lessons from transmissible cancers for immunotherapy and transplant RCMC Silva, C Panis, BRB Pires Immunological Medicine 45 (3), 146-161, 2022 | 1 | 2022 |
Reactive oxygen species and redox signaling in breast cancer C Panis, BRB Pires, AC De Andrade, MB Silva, VJ Victorino CRC PRESS, 2017 | 1 | 2017 |
Avaliação do papel de NF-κ B na regulação de fatores de transcrição envolvidos com a transição epitélio-mesenquimal em modelos in vitro de câncer de mama BRB Pires | 1 | 2014 |